Campbell Soup Company

CPB

Campbell Soup Company is a leading American food manufacturer in the packaged goods industry.
It is a household staple known for its iconic brands, such as Campbell's soups, and maintains a strong market position built on long-standing consumer trust and reliable pantry-stable products.

$26.95 +0.09 (+0.34%)

Updated: February 27, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy CPB Today?

Based on the provided data, here is a comprehensive analysis on whether CPB (Campbell Soup) is worth buying.

Analysis Summary

CPB presents a complex, mixed picture for investors. On one hand, the stock is technically weak, trading near its 52-week low with significant recent underperformance. The company's valuation appears modest based on P/E ratios, and its defensive, negative beta could offer a hedge in a down market. Fundamentally, it shows positive recent revenue growth and a commitment to shareholders via its dividend.

However, concerning factors are prominent. The high EV/EBITDA ratio signals a potentially expensive valuation when debt is considered. More critically, the company's liquidity is constrained with a current ratio below 1 and minimal cash, which could pose risks. Operational efficiency is also lackluster, with low returns on equity and assets.

Recommendation: HOLD

CPB is not a compelling buy at this time. While the stock appears cheap on some metrics and offers a dividend, the significant technical weakness, poor liquidity position, and mixed operational efficiency create substantial headwinds. Investors should wait for signs of improved financial health and a clearer technical reversal before considering a position. The stock may be suitable for very patient, income-focused investors who can tolerate its high volatility and fundamental risks.

*Note: This is not investment advice, for reference only.*

CTA Banner

CPB 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, the 12-month outlook for CPB is cautious. Key catalysts for a potential rebound would be a successful execution of its strategic plan to improve operational efficiency and a strengthening of its liquidity position, which could restore investor confidence. The primary risks remain its constrained financial health, evidenced by the low current ratio, and persistent technical weakness that could lead to further price erosion. Given the mixed fundamentals and lack of a clear positive catalyst, the stock is likely to remain range-bound, trading closer to its 52-week lows, with a target range challenging to define in the absence of analyst consensus but skewed to the downside from the current $26.86.

Wall Street Consensus

Most Wall Street analysts are optimistic about Campbell Soup Company's 12-month outlook, with consensus target around $26.95, indicating expected upside potential.

Average Target
$26.95
20 analysts
Implied Upside
+0%
vs. current price
Analyst Count
20
covering this stock
Price Range
$22 - $35
Analyst target range
Buy Buy
3 (15%)
Hold Hold
13 (65%)
Sell Sell
4 (20%)

Bulls vs Bears: CPB Investment Factors

Overall, CPB has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Attractive Dividend Yield: Stock offers a high 5.5% yield, which is appealing to income investors.
  • Significant Price Decline: Stock is down 32%, potentially making it oversold and undervalued.
  • Stable Demand Segment: Steady at-home cooking trends may support Meals & Beverages sales.
Bearish Bearish
  • Disappointing Q1 2026 Results: Company reported a decrease in both top and bottom lines.
  • Analyst Price Target Cuts: Analysts slashed price targets following weak quarterly earnings.
  • Cost and Tariff Pressures: Faces headwinds from higher marketing costs and tariff pressures.
  • Stock at 52-Week Low: Hitting new lows signals persistent negative investor sentiment.
Reward Banner

CPB Technical Analysis

CPB has demonstrated notably weak price performance with substantial declines across multiple timeframes amid significant downside volatility.

The stock has declined 1.86% over one month and 12.79% over three months, substantially underperforming the market by 18.42 percentage points during the latter period. This significant underperformance, combined with a negative beta indicating inverse correlation to market movements, highlights CPB's defensive characteristics during this downtrend.

Currently trading at $26.86, CPB sits just 4.8% above its 52-week low and 38.7% below its 52-week high, positioning the stock near oversold territory. The substantial 37.96% maximum drawdown over the past year further confirms the stock's deeply depressed technical condition relative to its recent trading range.

šŸ“Š Beta
-0.04
-0.04x market volatility
šŸ“‰ Max Drawdown
-38.0%
Largest decline past year
šŸ“ˆ 52-Week Range
$26-$44
Price range past year
šŸ’¹ Annual Return
-32.7%
Cumulative gain past year
Period CPB Return S&P 500
1m -0.1% -1.4%
3m -14.9% +4.1%
6m -16.8% +7.5%
1y -32.7% +15.4%
ytd -2.7% +0.4%

CPB Fundamental Analysis

Revenue & Profitability CPB exhibited strong revenue growth, increasing from $2.32 billion to $2.68 billion quarter-over-quarter, which translated into improved profitability metrics. The net income margin expanded from 6.25% to 7.25%, indicating better bottom-line conversion. However, the gross profit margin declined slightly from 30.37% to 29.59%, suggesting some pressure on input costs or pricing.

Financial Health The company maintains a moderate debt ratio of 45.9%, supported by a reasonable interest coverage ratio of 4.16. However, liquidity appears constrained with a current ratio of 0.82 and a very low cash ratio of 0.05, highlighting potential short-term cash flow challenges. The cash conversion cycle of 27.6 days demonstrates efficient management of working capital.

Operational Efficiency CPB's operational efficiency is mixed, with a return on equity of 4.9% reflecting modest shareholder returns. The asset turnover ratio of 0.18 indicates relatively low efficiency in generating sales from its asset base. The company's dividend payout ratio of 62% suggests a strong commitment to returning capital to shareholders despite moderate operational returns.

Quarterly Revenue
$2.3B
2025-08
Revenue YoY Growth
-2.0%
YoY Comparison
Gross Margin
30.4%
Latest Quarter
Free Cash Flow
$0.9B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is CPB Overvalued?

Valuation Level: Campbell Soup trades at a reasonable valuation based on earnings metrics. The trailing and forward P/E ratios of 13.3 and 11.5 suggest the stock is modestly priced, while a PEG ratio significantly below 1 at 0.35 indicates potential undervaluation relative to its expected earnings growth. However, the elevated EV/EBITDA ratio of 36.0 signals a much higher valuation when considering debt and other capital structure factors, presenting a mixed picture.

Peer Comparison: Without specific industry average data, a definitive peer comparison cannot be made. Generally, a forward P/E in the low teens for a stable consumer staples company like Campbell Soup is often considered fair or slightly discounted compared to the broader market. The high EV/EBITDA is atypical and would require industry context to determine if it is an outlier or consistent with sector peers facing similar capital structures.

PE
13.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -1164Ɨ-40Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/EBITDA
36.0x
Enterprise Value Multiple

Investment Risk Disclosure

Based on the provided metrics, CPB demonstrates extremely low volatility risk relative to the broader market. The negative beta of -0.036 indicates the stock has historically moved inversely to market swings, potentially offering a hedge but also behaving unconventionally. However, the substantial 1-year maximum drawdown of -37.96% reveals that despite its low correlation, the stock has experienced significant individual price depreciation during recent market stress.

The stock appears to carry minimal pressure from short sellers, as indicated by the negligible short interest, which suggests a lack of strong negative speculative sentiment. While this is positive, the extremely low beta could also signal low trading liquidity, potentially making large transactions difficult to execute without impacting the price.

FAQs

Is CPB a good stock to buy?

Based on the analysis, my opinion is bearish.

Core reasons include disappointing earnings leading to significant price declines and analyst downgrades, combined with mounting cost pressures and weak liquidity metrics. While the high dividend yield and oversold condition offer some appeal, the negative fundamentals and sentiment outweigh these factors.

This stock may only suit high-risk, income-focused investors who can tolerate further downside for the dividend and are betting on a speculative turnaround. Most investors should wait for clearer signs of operational improvement.

Is CPB stock overvalued or undervalued?

Based on the data provided, CPB appears undervalued relative to its earnings growth potential, though it is not cheap on all metrics. The key valuation metrics are its attractively low forward P/E of 11.5 and a PEG ratio of 0.35, which is significantly below 1, indicating the market may be undervaluing its future earnings growth. However, the high EV/EBITDA ratio of 36.0 signals a premium valuation when considering its capital structure. The core reason for the undervaluation call is the compelling PEG ratio, which suggests the stock's price does not fully reflect its earnings growth trajectory, especially for a stable consumer staples company.

What are the main risks of holding CPB?

Based on the provided analysis, here are the key risks of holding CPB stock, ordered by importance:

1. Liquidity Risk: The company's critically low cash ratio (0.05) and current ratio (0.82) indicate significant vulnerability to meeting short-term obligations and potential cash flow distress. 2. Market/Liquidity Risk: Despite its low beta, the stock has experienced a severe maximum drawdown of -37.96% and trades near its 52-week low, suggesting high idiosyncratic volatility and potentially low trading liquidity that can exacerbate price declines. 3. Operational Efficiency Risk: A low asset turnover ratio (0.18) and a modest return on equity (4.9%) indicate the company is inefficient at utilizing its assets to generate sales and profits for shareholders. 4. Profitability Pressure Risk: The recent decline in gross profit margin (from 30.37% to 29.59%) signals rising input costs or pricing pressure that could threaten future earnings growth despite recent revenue increases.

What is the price forecast for CPB in 2026?

Based on the provided analysis, my forecast for CPB stock through 2026 is cautious, with a base case target range of $24-$28 and a bull case requiring successful execution of its strategic plan to reach the low $30s. Key growth drivers are the improvement of operational efficiency to boost asset turnover and the strengthening of its liquidity position to alleviate short-term cash constraints. The main assumptions are that management can stabilize margins and navigate input cost pressures, but the forecast carries high uncertainty due to the company's weak liquidity and lack of a clear positive catalyst, making sustained growth challenging.